HALOZYME THERAPEU.DL-,001 earnings per share and revenue

RV7 earnings per share for the last quarter are 0.73 EUR whereas the estimation was 0.64 EUR which accounts for 15.07% surprise. Company revenue for the same period amounts to 181.54 M EUR despite the estimated figure of 185.12 M EUR. Estimated earnings per share for the next quarter are 0.69 EUR, and revenue is expected to reach 185.17 M EUR. Also watch annual changes over time to get a bigger picture of RV7 earnings per share and revenue dynamics.